Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07846397
NA

Non-invasive Induction of Metaplasticity for Amblyopia

Sponsor: Boston Children's Hospital

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to determine the efficacy of flicker therapy as an adjunct therapy to treat amblyopia beyond the critical period in adolescents and adults aged 14-40 years who have amblyopia of ≥3 lines of interocular best-corrected (with glasses) visual acuity difference. The main questions it aims to answer are: * Does flicker therapy enable clinically meaningful and durable visual recovery from amblyopia? * Do flicker therapy-treated patients show a change in amblyopic eye visual acuity (lines)? Participants will undergo daily flicker therapy for 1 hour per day.

Official title: Non-invasive Induction of Metaplasticity to Treat Amblyopia in Adolescent and Adult Patients

Key Details

Gender

All

Age Range

14 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2026-11

Completion Date

2027-03

Last Updated

2026-09-29

Healthy Volunteers

No

Interventions

DEVICE

Flicker

The device is intended for investigational use in children (14 years old and up) and adults with amblyopia to evaluate the once daily use (up to 2 hours) over the study period of 8 weeks. Key characteristics of the system include: * Non-implantable * Externally applied * No electrical stimulation delivered to the body * No invasive components or procedures * No life-sustaining or life-supporting function The device consists of a handheld, battery-powered controller, an eyeset, and a power charger. The device is intended for daily use at home.